CRON vs GILD · P/E 14, rev $117.6M vs P/E 18, rev $29.44B
Cronos Group Inc (CRON) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CRON revenue for 2024-12-31 was $117.6M. Net income was $40.0M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CRON currently screens at market cap $738.3M and trailing P/E 13.6. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CRON and GILD stock pages for the full models.
Not investment advice.